Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a quaternary ammonium compound with anticholinergic and antispasmodic properties. It is primarily used to reduce smooth muscle spasms.
## Primary Indications
* Symptomatic relief of gastrointestinal spasms and hypermotility.
* Adjunct in the treatment of peptic ulcer disease.
## Adult Dosing
* **Oral:** 15-30 mg three times daily, taken 30 minutes before meals and at bedtime. Maximum daily dose is not well-established but generally kept below 120 mg/day.
## Pediatric Dosing
* Information on pediatric dosing is limited and not well-established. Use with caution and at the discretion of the prescriber.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are established. Use with caution due to potential for accumulation.
* **Hepatic Impairment:** No specific dose adjustments are established. Use with caution.
## Contraindications
* Glaucoma (angle-closure suspected or confirmed).
* Myasthenia gravis.
* Tachyarrhythmias.
* Known hypersensitivity to walethmade bromide or other anticholinergics.
* Gastrointestinal obstruction or atony.
* Unstable cardiovascular status in acute hemorrhage.
## Adverse Effects
* **Common:** Dry mouth, blurred vision, urinary retention, constipation, drowsiness, dizziness.
* **Serious:** Tachycardia, confusion, exacerbation of glaucoma, heat prostration.
## Key Drug Interactions
* **Anticholinergics:** Additive anticholinergic effects with other drugs possessing anticholinergic properties (e.g., tricyclic antidepressants, antihistamines, antiparkinsonian agents).
* **Potassium Chloride:** Increased risk of gastrointestinal ulceration and bleeding when co-administered with potassium chloride preparations.
* **Proton Pump Inhibitors (PPIs) / H2 Blockers:** May decrease the efficacy of PPIs and H2 blockers by increasing gastric pH and reducing the need for acid suppression.
## Monitoring
* Monitor for signs of anticholinergic side effects (dry mouth, blurred vision, urinary retention, constipation).
* Monitor for signs of CNS effects (drowsiness, confusion).
* Assess efficacy in relieving gastrointestinal symptoms.
## Clinical Pearls
* Administer 30 minutes before meals and at bedtime to maximize efficacy for GI spasms.
* Advise patients to avoid activities requiring mental alertness until they know how this medication affects them.
* Caution patients regarding potential for heat prostration in hot weather due to decreased sweating.
* Due to limited pediatric data, consider alternative agents if available and appropriate.
---
*Disclaimer: This information is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional and refer to the most current prescribing information for any medication before making treatment decisions.*
